Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy

NCT03821246 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

68

Enrollment

OTHER

Sponsor class

Conditions

Prostate Adenocarcinoma
Prostate Cancer
Localized Prostate Cancer

Interventions

DRUG: Atezolizumab
DRUG: Tocilizumab
DRUG: Etrumadenant

Sponsor

David Oh

Collaborators

[object Object]
[object Object]